ARTHROPLASTY
Extended thromboprophylaxis beneficial after total knee arthroplasty
Thromb Res. 2010 Oct;126(4):e298-304857 patients having undergone total knee arthroplasty (TKA) were randomized to receive either short term thromboprophylaxis, where therapy would stop at day 10 +/- 2, or extended thromboprophylaxis, where therapy would stop at day 35 +/- 5. Patients were assessed for proximal or symptomatic deep vein thrombosis (DVT), pulmonary embolism (PE), major bleeding, thrombocytopenia, and mortality up to day 35 +/- 5 (primary outcome). The secondary outcome was ultrasonographic distal deep vein thrombosis at day 35 +/- 5. The rates of the primary and secondary outcomes were found to be higher in the short therapy group.
Unlock the full ACE Report
You have access to {0} free articles per month.Click below to unlock and view this {1}
Unlock NowCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidence content for just $1.99 per week.
Already have an account? Log in
Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.
{0} of {1} free articles
Become an OrthoEvidence Premium Member. Expand your perspective with high-quality evidence.
Upgrade Now
